Researchers at Massachusetts General Hospital (MGH) led by Harvard Stem Cell Institute Principal Faculty Harald C. Ott M.D. have generated the embryonic cells that support early heart development.

... Read more about Researchers generate protective embryonic heart cells

HSCI researchers led by Tracy Young-Pearse, Ph.D., have developed a method to examine living brain cells and predict the rate of Alzheimer’s disease progression and cognitive decline.

... Read more about New brain model sheds patient-specific light on Alzheimer’s disease

HSCI researchers use patient-derived motor neurons to screen for clinically relevant targets

Harvard and Broad researchers combine single-cell genomic technologies to map the mouse cortex

CALL FOR PROPOSALS

FALL 2021 HSCI COLLABORATIVE SEED GRANTS

AWARD AMOUNT
$100,000 per project per year for up to two years
POSTED DATE
Monday, June 21, 2021
DEADLINE FOR APPLICATION
Friday, September 17, 2021
ANTICIPATED AWARD DATE
Monday, November 1, 2021
 

The Harvard Stem Cell Institute (HSCI) invites applications for seed grant funding for its Fall 2021 cycle.

The purpose of this program is to provide funding for innovative projects in the field of stem cell and regenerative biology that are a collaboration between two labs. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures. However, proposals at all stages of development are welcome. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.... Read more about Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

HSCI researchers identify mechanism with therapeutic potential for anemia

HSCI researchers identify new potential target for obesity therapy

HSCI researchers identify mechanism for regenerating hair follicle stem cells

New strategy to cloak AAVs from unwanted immune responses

The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy

Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research. The JDRF Center of Excellence in New England will focus on the transplantation of beta cells, the insulin-producing cells of the pancreas that are attacked by the immune system during type 1 diabetes.

The center is also led by JDRF scientific staff leader Esther Latres, Ph.D. Other collaborators include...

HSCI researchers create ON-OFF switches to better control CAR T cell activity

HSCI scientists have created molecular ON-OFF switches to regulate the activity of CAR T cells, a potent form of cell-based immunotherapy that has shown dramatic success in treating some...

Researchers develop a method to sequence DNA while preserving its physical structure inside the cell